Serum 25-Hydroxyvitamin D and Subsequent Cancer Incidence and Mortality: A Population-Based Retrospective Cohort Study
To determine the relationship between 25-hydroxyvitamin D (25[OH]D) values and subsequent cancer incidence and mortality. We identified all adult patients living in Olmsted County, Minnesota, between January 1, 2005, and December 31, 2011, who had at least 1 25(OH)D measurement and no prior diagnosi...
Saved in:
| Published in: | Mayo Clinic proceedings Vol. 96; no. 8; pp. 2157 - 2167 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Elsevier Inc
01-08-2021
Elsevier, Inc |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | To determine the relationship between 25-hydroxyvitamin D (25[OH]D) values and subsequent cancer incidence and mortality.
We identified all adult patients living in Olmsted County, Minnesota, between January 1, 2005, and December 31, 2011, who had at least 1 25(OH)D measurement and no prior diagnosis of cancer. Cancer outcomes were retrieved starting 30 days after 25(OH)D measurement and until patients’ final clinical visit as an Olmsted County resident; December 31, 2014; or death. Cox proportional hazards regression was used to analyze data.
A total of 8700 individuals had a 25(OH)D measurement and no history of cancer, with a mean ± SD 25(OH)D value of 29.7±12.8 ng/mL (to convert to nmol/L, multiply by 2.496). The mean ± SD age was 51.5±16.4 years, and most were women (78.1%; n=6796) and White (85.7%; n=7460). A total of 761 individuals developed cancer (skin cancer, n=360; nonskin cancer, n=401) during a median follow-up of 4.6 (interquartile range, 3.4-6.1) years. Compared with participants with 25(OH)D values of 20 to 50 ng/mL (reference group), those with 25(OH)D values less than 12 ng/mL had a greater nonskin cancer incidence (hazard ratio [HR], 1.56; 95% CI, 1.03 to 2.36; P=.04) after adjustment. There was no association between 25(OH)D values and total cancer or skin cancer incidence. Compared with individuals from the reference group, 25(OH)D levels less than 12 ng/mL (HR, 2.35; 95% CI, 1.01 to 5.48; P=.047) and 12 to 19 ng/mL (HR, 2.10; 95% CI, 1.05 to 4.22; P=.04) were associated with increased cancer mortality.
Low 25(OH)D levels were associated with increased risk for incident nonskin cancer and cancer-related mortality. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Dr. Dudenkov conceptualized and designed the study, analyzed and interpreted the data, and critically reviewed and revised the manuscript. Dr. Fischer conceptualized and designed the study, analyzed and interpreted the data, and critically reviewed and revised the manuscript. Ms. Mara acquired the data, analyzed and interpreted the data, and critically reviewed and revised the manuscript. Dr. Johnson conceptualized and designed the study, analyzed and interpreted the data, drafted the initial manuscript, and critically reviewed and revised the manuscript. Contributors All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. Dr. Thacher conceptualized, designed, and provided oversight for the study, acquired funding, analyzed and interpreted the data, and critically reviewed and revised the manuscript. Ms. Maxson conceptualized and designed the study, analyzed and interpreted the data, and critically reviewed and revised the manuscript. |
| ISSN: | 0025-6196 1942-5546 |
| DOI: | 10.1016/j.mayocp.2020.12.037 |